SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-19-008119
Filing Date
2019-02-14
Accepted
2019-02-14 16:17:21
Documents
1
Group Members
ARMEN B. SHANAFELT, PH.D.LV MANAGEMENT GROUP, LLCS. EDWARD TORRESSTEVEN E. HALL, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G tv513503_sc13g.htm SC 13G 124049
  Complete submission text file 0001144204-19-008119.txt   125817
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Subject) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90656 | Film No.: 19606568
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204
Business Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204 (317) 429-0140
Lilly Ventures Fund I LLC (Filed by) CIK: 0001575852 (see all company filings)

IRS No.: 264769290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G